Home
Peptide based therapies for neurodegenerative conditions
PUBLISHED
2021-09-06
Content
Dougal Thring - VP Clinical Development - NeuroScientific Biopharmaceuticals is developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical needs.